* 1. What country are you from ?

* 2. Please specify the type of hospital in which you practice:

* 3. Please specify your clinical experience in the field of prostate cancer:

* 4. Is there a multidisciplinary oncological team involved in the management of prostate cancer in your hospital?

* 5. If yes, please select the specialists present:

* 6. Please specify how many radical prostatectomies do you perform yearly:

* 7. Please specify if MRI is available for preoperative imaging evaluation of prostate cancer in your hospital:

* 8. If yes, please specify the type of MRI :

* 9. What type of EBRT is available in your hospital ?

* 10. In your country, what is the current health care policy regarding the hormonal treatment ?

* 11. What is your definition of high-risk prostate cancer ?

* 12. What is your definition of very-high-risk prostate cancer ?

* 13. Do you use nomograms to assess the pretreatment risk of patients with prostate cancer

* 14. If yes, please select what nomograms you use?

* 15. How do you usually stage high-risk prostate cancer with imaging ?

* 16. What is your current practice regarding the management of high-risk prostate cancer ?

* 17. What is your definition of biochemical recurrence after radical prostatectomy ?

* 18. What is your definition of biochemical recurrence after EBRT ?

* 19. What is your definition of local recurrence after radical prostatectomy ?

* 20. In which cases do you offer adjuvant EBRT after radical prostatectomy ?

* 21. When do you offer adjuvant EBRT after radical prostatectomy ?

* 22. In which cases do you offer adjuvant hormonal treatment after radical prostatectomy ?

* 23. In which cases do you offer salvage EBRT after radical prostatectomy ?

* 24. In which cases do you offer salvage hormonal treatment after radical prostatectomy ?

* 25. What type of approach do you prefer when performing radical prostatectomy in high risk patients ?

* 26. Do you preserve the NVB, if technically feasible, in high-risk PC patients?

* 27. What template do you use for pelvic lymphadenectomy in patients with high-risk prostate cancer ?

* 28. Please specify if you use intraoperative frozen section to prove lymph node invasion:

* 29. If yes, do you abandon the procedure if lymph node invasion is proven?

* 30. Please specify the method of submission of the lymph node tissue to the pathologist:

* 31. What is the minimal nodal yield required for an accurate pelvic lymphadenectomy in high-risk patients ?

* 32. Do you have confidence in your pathologist?

* 33. Do you personally evaluate the biopsy specimens under microscope?

* 34. If yes, please specify the correlation between the biopsy results and the final Gleason score of the prostatectomy specimen:

T